Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Germany flag Germany · Delayed Price · Currency is EUR
1.270
+0.040 (3.25%)
Last updated: Apr 23, 2026, 8:10 AM CET
Market Cap7.09B -11.8%
Revenue (ttm)34.53B +3.0%
Net Income697.07M +25.7%
EPS0.19 +25.3%
Shares Outn/a
PE Ratio10.18
Forward PE13.12
Dividend0.05 (3.94%)
Ex-Dividend DateDec 29, 2025
Volumen/a
Average Volume58
Open1.270
Previous Close1.230
Day's Range1.270 - 1.270
52-Week Range1.160 - 1.420
Betan/a
RSI47.35
Earnings DateMar 30, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1994
Employees 49,608
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol S1R

Financial Performance

In 2025, FRA:S1R's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY Financial Statements